Document:

Exhibit 10.26

    

    

    RESTRICTED STOCK AGREEMENT

    

    

    THIS RESTRICTED STOCK AGREEMENT
      (this “Agreement”) is made effective as of the [__] day of [____], 2021 (the “Grant Date”), by and between Cue Health Inc., a Delaware corporation (the “Company”), and
      [___], an individual resident of [____] (“Participant”).

    

    

    W I T N E S S E T H

    

    

    WHEREAS, the Company desires to
      grant [___] shares of the Company’s Common Stock, par value $0.00001 per share (the “Shares”), under the Amended and Restated Cue Health
      Inc. 2014 Equity Incentive Plan, as amended (the “Plan”), to Participant; and

    

    

    WHEREAS, the Company has
      determined that it is in the best interests of the Company to grant the Shares to Participant on the terms and conditions as set forth herein.

    

    

    NOW, THEREFORE, in consideration
      of the mutual promises and covenants set forth herein, the parties, intending to be legally bound, hereby agree as follows.

    

    

    A G R E E M E N T

    

    

    1.          

    Grant of the Shares.  The
        Shares are issued, subject to the terms and conditions of this Agreement and the Plan, to the Participant, effective as of the Grant Date.

    

    

    2.          

    Representations and Warranties of the
            Company.  The Company hereby represents and warrants to Participant:

    

    

    2.1          

    The Shares, when issued, will be duly authorized, validly issued and fully paid and non-assessable, and have not been
        issued in violation of any preemptive right or similar right of any person or of any federal or state law.

    

    

    2.2          

    The Company has full power, legal right and authority to enter into, execute and deliver this Agreement and to carry out
        the transactions contemplated hereby and thereby.

    

    

    2.3          

    Neither the execution and delivery by the Company of this Agreement (i) will violate any law or order applicable to the
        Company, or (ii) will require any authorization, consent or approval by, filing with or notice to any governmental entity, or (iii) will result in the creation of any lien upon any of the shares or any of the material assets of the Company.

    

    

    3.          

    Representations, Warranties of Covenants
            of Participant.  The Participant hereby represents, warrants and covenants to the Company as follows:

    

    

    3.1          

    Participant has full power, legal right and authority to enter into, execute and deliver this Agreement and to carry out
        the transactions contemplated hereby and thereby.

    

    

    3.2          

    Participant is acquiring the Shares for his own account and not with a view to, or for resale in connection with, any
        “distribution” within the meaning of the Securities Act of 1933, as amended (the “1933 Act”), or any applicable state securities laws, and
        the Shares will not be disposed of in contravention of the 1933 Act of any applicable state securities laws.

    
      
        

    

     3.3          

    Participant is sophisticated in financial matters and is able to evaluate the risks and benefits of his investment in
        the Shares.  Participant is capable of bearing the economic risk and burden of the investment for an indefinite period of time and the possibility of complete loss of all of the investment in the Shares, and the restrictions on transfer under this
        Agreement and under applicable securities laws such that it may not be possible to readily liquidate the investment whenever desired.

    

    

    3.4          

    Participant acknowledges that the Company has made available to him the opportunity to obtain information regarding the
        business and financial condition of the Company.  Participant also acknowledges that it has had an opportunity to ask questions of the personnel of the Company regarding the financial condition and prospects of the Company, and to the extent the
        Participant has taken advantage of such opportunity, has received satisfactory answers concerning such matters.

    

    

    3.5          

    Participant has obtained, to his satisfaction, advice regarding the legal and tax consequences of this Agreement from
        his own legal and tax advisors.  The Company has not provided legal or tax advice to the Participant.

    

    

    3.6          

    Participant understands that the Company is under no obligation to register the Shares or to make any exemption from
        registration available.  Participant understands that any instruments evidencing the Shares will be imprinted with a legend prohibiting the transfer of the Shares unless they are registered or such registration is not required in the opinion of
        counsel satisfactory to the Company.

    

    

    3.7          

    Participant is aware of the adoption of Rule 144 by the Securities and Exchange Commission, promulgated under the 1933
        Act, which permits limited public resale of shares acquired in a non-public offering subject to the satisfaction of certain conditions.  Participant further acknowledges and understands that if the Company is not satisfying the current public
        information requirement of Rule 144 at the time Participant wishes to sell the Shares, Participant would be precluded from selling the Shares under Rule 144 even if the minimum holding period has been satisfied.

    

    

    3.8          

    At no time was Participant presented with or solicited by any leaflet, public promotional meeting, circular, newspaper
        or magazine article, radio or television advertisement, or any other form of general advertising.

    

    

    3.9          

    Participant has a good understanding of the English language and is a resident of the jurisdiction indicated above.

    

    

    3.10          

    Participant understands that, in transferring the Shares, the Company has relied upon an exemption from registration
        under the Securities Act and that, in an attempt to effect compliance with all the conditions thereof and the applicable state law exemption, the Company is relying in good faith upon all of the foregoing representations and warranties on the part
        of Participant.

    

    

    3.11          

    Participant’s spouse (if any) has executed and delivered to the Company a Spousal Consent in the form attached hereto as
        Exhibit A with respect to the Shares.

    
      
        

    

    4.          

    Vesting and One-Year Holding Requirement.

    

    

    4.1          

    Vesting. 
        The Shares shall be fully vested upon the Grant Date.

    

    

    4.2          

    Holding Requirement. 
        Notwithstanding the foregoing, Participant may not sell or otherwise transfer the Shares issued pursuant to this award until after the date that is one (1) year after the Grant Date.

    

    

    4.3          

    Legends.
        All book entry positions representing the Shares shall have affixed thereto legends in substantially the following form, in addition to any other legends that may be required under federal or state securities laws:

    

    

    “The shares represented hereby have not been registered under the Securities Act of 1933, as amended, and may not be sold, transferred
      or otherwise disposed of in the absence of an effective registration statement under such Act or an opinion of counsel satisfactory to the corporation to the effect that such registration is not required.”

    

    

    “The shares of stock represented hereby are subject to restrictions on transfer set forth in a certain Restricted Stock Agreement
      between the corporation and the registered owner of the shares”.

    

    

    5.          

    Miscellaneous.

    

    

    5.1          

    Further Assurances.  The
        parties hereby agree to cooperate and take all actions reasonably necessary to effectuate the transactions contemplated by this Agreement.

    

    

    5.2          

    Successors and Third Party Beneficiaries. 
        This Agreement shall be binding upon and inure to the benefit of the Company and its respective successors and assigns and Participant and his respective successors and assigns.  This Agreement cannot be assigned by the Company or Participant
        without the express written consent of the other party.

    

    

    5.3          

    No Collateral Agreements. 
        This Agreement and the Plan constitute the entire agreement between the parties with respect to the transaction contemplated hereby and all prior oral and written agreements as to the subject matter set forth herein are deemed replaced and
        superseded by this Agreement and the Plan.

    

    

    5.4          

    Notices.  All notices,
        requests, demands, or other communications hereunder shall be in writing and shall be deemed given when deposited in the U.S. mail, postage prepaid, addressed as indicated below:

    

    

    (a)          If to Participant, to their address as
        indicated in the records of the Company.

    

    

    (b)          If to the Company, to:

    

    

    Cue Health Inc.

    4980 Carroll Canyon Rd.

    Suite 100

    San Diego, CA 92121

    

    

    with a copy to:

    

    

    WilmerHale

    2600 El Camino Real

    Suite 400

    Palo Alto, CA 94306

    Attention: E. Thom Rumberger, Jr., Esq.

    
      
        

    

     5.5          

    Headings.  All article and
        section headings are inserted for convenience only and shall not affect the interpretation of this Agreement.

    

    

    5.6          

    Counterparts.  This Agreement
        may be executed in one or more counterparts, each of which shall be deemed an original, but which together shall constitute one and the same instrument.

    

    

    5.7          

    Facsimile Execution. 
        Delivery of an executed counterpart of this Agreement or any other instrument or document contemplated hereby by facsimile or electronic mail shall be equally effective as delivery of a manually executed counterpart.  Any party that delivers any
        such counterpart by facsimile or electronic mail shall also deliver a manually executed counterpart, but the failure to do so shall not affect the validity, enforceability or binding effect of the applicable agreement, instrument or document.

    

    

    5.8          

    Governing Law.  This
        Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, excluding any choice of law rules that may direct the application of the laws of another jurisdiction.

    

    

    [Signature Page to Follow]

    
      
        

    

     IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be made as of the date and year first above written.

    

    

    	 	
            PARTICIPANT:

          
	 	 
	 	 
	 	
            [____], Individually

          
	 	 
	 	
            COMPANY:

          
	 	 
	 	
            Cue Health Inc.

          
	 	 
	 	
            By:

          	 
	 	
            Name:

          	
            Ayub Khattak

          
	 	
            Title:

          	
            Chief Executive Officer

          

    
      
        

    

     SPOUSAL CONSENT

    

    

    I, [_____], spouse of [____], have read and approve of the foregoing Restricted Stock Agreement, dated as of [____], together with all
      exhibits and attachments thereto (collectively, the “Agreement”), by and between my spouse and Cue Health Inc., a Delaware corporation (the “Company”).  In consideration of the Company’s granting of [____] shares of the Common Stock of the Company as set forth in the Agreement, I hereby
      appoint [____] as my attorney-in-fact in respect to the exercise or waiver of any rights under the Agreement, and agree to be bound by the provisions of the Agreement insofar as I may have any rights in said Agreement or any shares issued pursuant
      thereto that I may have a community property interest or similar laws relating to marital property in effect in the state of our residence as of the date of the signing of the foregoing Agreement.

    

    

    	
            Dated:

          	 	
            “Spouse of Participant”

          
	 	 
	 	 
	 	
            (Signature)

          
	 	 
	 	 
	 	
            (Print Name)EXHIBIT 10.1

 

SECOND AMENDMENT TO 

THIRD AMENDED AND RESTATED
COOPERATION AGREEMENT

This Second Amendment, dated as of September
15, 2021 (this “Amendment”), to the Third Amended and Restated Cooperation Agreement is by and among Avis Budget
Group, Inc. (the “Company”) and the entities set forth on Schedule A hereto (together with their Affiliates,
“SRS”).

WHEREAS, the Company and SRS have previously entered
into that certain Third Amended and Restated Cooperation Agreement dated as of February 23, 2020 as amended by that certain Amendment
to Third Amended and Restated Cooperation Agreement dated as of August 12, 2020 (as so amended prior to the date hereof, the “Agreement”),
with respect to certain matters relating to the Board of Directors of the Company and certain other matters, as provided therein; and

WHEREAS, the Company and SRS desire to extend
the Standstill Period (as defined therein) and make certain other amendments to the Agreement as set forth herein.

NOW THEREFORE, in consideration of the covenants
and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
the Company and SRS wish to amend the Agreement on the terms set forth herein, and agree as follows:

1.          Amendments to the Agreement.

(a)           The first sentence of Section 2 of the Agreement is amended and restated in its entirety as follows:

“During the period commencing with the
execution and delivery of this Agreement and ending on the earliest to occur of (i) December 31, 2022, (ii) the date on which SRS’s
Beneficial Ownership ceases to satisfy the Minimum Ownership Level set forth in Section 5(b) hereof and (iii) the date that is
sixty (60) calendar days prior to the Advance Notice Deadline (the “Standstill Period”), SRS shall not, directly or
indirectly, in any manner, take any of the following actions (unless specifically permitted to do so in writing in advance by the Board):”

(b)          The last sentence of Section 14 of the Agreement is amended and restated in its entirety as follows:

“In the event the Company determines to
hold the 2023 Annual Meeting (as defined below) more than twenty-five (25) days before or twenty-five (25) days after the one-year anniversary
of the 2022 annual meeting of stockholders, the Company will provide notice to SRS of the Advance Notice Deadline no later than seventy-five
(75) days prior to the Advance Notice Deadline. ”

     

     

    

 

(c)          Section 15(a) of the Agreement is amended and restated in its entirety as follows:

“Advance Notice Deadline”
means the advance notice deadline as determined pursuant to the Company’s bylaws, as then in effect, for stockholders to nominate
candidates for the annual meeting of stockholders following the 2022 annual meeting of stockholders (the “2023 Annual Meeting”).

2.          Defined Terms. All capitalized terms used in this Amendment but not specifically defined herein shall have the same
meanings given such terms in the Agreement.

3.          Ratification of Agreement. Except as set forth herein, the Agreement shall remain unmodified and in full force and
effect.

4.          Counterparts. This Amendment may be executed in two or more counterparts, which together shall constitute a single
agreement.

5.          Governing Law. This Amendment shall be governed by and construed and enforced in accordance with the laws of the
State of Delaware without reference to the conflict of laws principles thereof.

 

[Signature Page Follows]

    	 	2	 

     

    

IN WITNESS WHEREOF, each of the parties hereto
have executed this Amendment or caused the same to be executed by its duly authorized representative as of the date first above written.

	 	Avis Budget Group,
Inc.	 
	 	 	 
	 	 	 
	 	By:	/s/ Jean M. Sera	 
	 	 	Name:

                                                                              Title:
	 Jean M. Sera
 Senior Vice President, General Counsel,
    Chief Compliance Officer and Corporate Secretary	 

 

 

 

 

[Signature Page to the Second Amendment to the Third
Amended and Restated Cooperation Agreement]

    	 		 

     

    

 

	 	SRS Investment Management, LLC
	 	 	 
	 	 	 
	 	By:	/s/ David B. Zales	 
	 	 	Name:

                                                                              Title:
	 David B. Zales  
 General Counsel  	 

 

 

	 	SRS Partners Master Fund LP
	 	 	 
	 	 	 
	 	By:	/s/ David B. Zales	 
	 	 	Name:

                                                                              Title:
	 David B. Zales  
 General Counsel  	 

 

 

	 	SRS Special Opportunities Master II, LP
	 	 	 
	 	 	 
	 	By:	/s/ David B. Zales	 
	 	 	Name:

                                                                              Title:
	 David B. Zales  
 General Counsel  	 

 

 

	 	SRS Long Opportunities
Master Fund, LP
	 	 	 
	 	 	 
	 	By:	/s/ David B. Zales	 
	 	 	Name:

                                                                              Title:
	 David B. Zales  
 General Counsel  	 

 

 

    	 		 

     

    

 

SCHEDULE A

 

SRS Investment Management, LLC

SRS Partners Master Fund LP

SRS Special Opportunities Master II, LP

SRS Long Opportunities Master Fund, LP

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}]]